A new stochastic model for subgenomic hepatitis C virus replication considers drug resistant mutants.

As an RNA virus, hepatitis C virus (HCV) is able to rapidly acquire drug resistance, and for this reason the design of effective anti-HCV drugs is a real challenge. The HCV subgenomic replicon-containing cells are widely used for experimental studies of the HCV genome replication mechanisms, for dru...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Nikita V Ivanisenko, Elena L Mishchenko, Ilya R Akberdin, Pavel S Demenkov, Vitaly A Likhoshvai, Konstantin N Kozlov, Dmitry I Todorov, Vitaly V Gursky, Maria G Samsonova, Alexander M Samsonov, Diana Clausznitzer, Lars Kaderali, Nikolay A Kolchanov, Vladimir A Ivanisenko
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2014
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/cb38672ba80c44689a4dc650e1639ee7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

A new stochastic model for subgenomic hepatitis C virus replication considers drug resistant mutants.

Ejemplares similares